FCF Grants Awarded in 2021
Total grants: 7
- Disruption of PKA RIα phase separation by the oncogenic fusion protein in FLC — Principal investigator(s): Jin Zhang — University of California at San Diego
- Liquid Biopsy for Active Surveillance of Fibrolamellar Hepatocellular Carcinoma — Principal investigator(s): Gary S. Stein — University of Vermont
- Molecular therapies for fibrolamellar carcinoma (FLC) – extension — Principal investigator(s): John Scott — University of Washington
- Development and validation of an orthotopic, syngeneic, mouse model for fibrolamellar hepatocellular carcinoma — Principal investigator(s): Mark Yarchoan — Johns Hopkins University
- Defining incidence of fibrolamellar carcinoma through computational analysis of multiple data types — Principal investigator(s): John Gordan — University of California at San Francisco
- CRISPR-engineering of human liver organoids to study fibrolamellar carcinoma — Principal investigator(s): Benedetta Artegiani — Princess Maxima Center for Pediatric Oncology
- A gene editing approach to develop new and effective models for FLC — Principal investigator(s): Sean Ronnekleiv-Kelly — University of Wisconsin
This list represents the complete set of Fibrolamellar Cancer Foundation grants awarded in 2021. The name of the grant is listed, along with the institution receiving the grant and the principal investigator.